TK Nucera stock fell 3.19 percent as outlook weighs on shares

Published on 10/05/2026 at 20:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TK Nucera stock was last at EUR 8.50 on October 5, 2026, down 3.19 percent. Fiscal 2026 EBIT guidance is EUR -105 million to EUR -75 million after the SOEC reset.

Aquarellmalerei der Dortmunder Skyline mit Fernsehturm und Fluss im Vordergrund — ThyssenKrupp Nucera (DE000NCA0001) hat seinen Sitz in Dortmund, hier dargestellt als sanfte Aquarell-Stadtansicht am Fluss, Illustration mit AI erstellt.

TK Nucera (ISIN DE000NCA0001) was last at EUR 8.50 on Xetra on October 5, 2026, down 3.19 percent from the prior close. The decline leaves the share 28.6 percent below its 52-week high of EUR 11.90, while the company balances stronger chlor-alkali demand against a weaker green hydrogen outlook.

SOEC reset weighs on guidance

According to Hydrogen Central on October 2, 2026, thyssenkrupp nucera abandoned plans for in-house mass production of solid oxide electrolysis cell stacks after assessing market timing and investment needs. The decision implies a one-time EBIT impact of roughly EUR 30 million in the fourth quarter, as reported for the August 11, 2026 announcement.

The revised fiscal 2026 outlook calls for group EBIT of EUR -105 million to EUR -75 million, compared with the previous range of EUR -80 million to EUR -30 million. Group sales are now expected at EUR 450 million to EUR 500 million, versus EUR 450 million to EUR 550 million previously, while order intake is guided at EUR 550 million to EUR 670 million.

Orders strengthen the core business

Operationally, the latest quarterly picture is mixed. The Q3 2025/2026 conference transcript published by Yahoo Finance identifies third-quarter order intake of EUR 81 million, up 29 percent year over year, while quarterly sales fell 21 percent to EUR 145 million. Chlor-alkali sales rose 34 percent to EUR 109 million, partly offsetting green hydrogen sales of EUR 36 million.

The same transcript shows first-nine-month order intake of EUR 471 million, nearly double the prior-year period, and an order backlog of EUR 638 million at the end of June 2026. Group EBIT for the first nine months was EUR -69 million, compared with EUR 4 million in the prior-year period, reflecting EUR 50 million of one-time project costs in green hydrogen.

A new China contract provides a counterweight to the guidance cut. EQS News reported on September 29, 2026, that Hongniu Lanzhou selected thyssenkrupp nucera for a chlor-alkali project in Northwest China worth a low double-digit million-euro amount. The contract covers licensing, engineering, procurement services, equipment supply and commissioning support.

Stock stays below yearly high

For investors, the key contrast is clear: order momentum is accelerating in the profitable chlor-alkali activity, while SOEC costs and project timing weigh on fiscal 2026 earnings. The company expects chlor-alkali sales of EUR 320 million to EUR 400 million and EBIT of EUR 45 million to EUR 65 million for the fiscal year.

TK Nucera was last at EUR 8.50 on Xetra on October 5, 2026, at 5:35 p.m. CEST. Its market capitalization was EUR 1.1 billion on that date, with a 52-week range of EUR 6.87 to EUR 11.90.